for Jan 04, 2020 through Jan 10, 2020
First issue of 2020 is now online featuring a theme issue on "challenging infections in the ICU", quadrivalent vs trivalent influenza vaccine, vancomycin prophylaxis in PJ surgery, optimising the design of antimicrobial stewardship interventions, and morehttps://t.co/11Bop25ZX7 pic.twitter.com/8TmuB3R42S
— Clinical Microbiology and Infection (@CMIJournal) January 5, 2020
NEW 🔥🔥 in #IJAA by @SIDPharm Dr. Nicolau group Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance #IDTwitter @ischemo https://t.co/bOZr05GgTh pic.twitter.com/pTy0BpWVg1
— Antibiotic Steward 🆔 (@ABsteward) January 8, 2020
NEW PODCAST: CDC’s Dr. Arjun Srinivasan joins leading experts in a new @IDSAInfo podcast “Antimicrobial Stewardship: Updates that Impact You.” Experts discuss CDC’s revised Core Elements and @CMSGov’s new requirement. Learn more: https://t.co/VCNFlTJMPn. pic.twitter.com/au7zIDBcvp
— CDC (@CDCgov) January 7, 2020
D#6. We commonly get asked by ICU to comment on positive respiratory cultures for Stenotrophomonas. Most represent colonization and not true infection. Here is a good study to have on this topic. https://t.co/YhIW3AhgTJ
— Carlos del Rio (@CarlosdelRio7) January 4, 2020
In Press! The Adverse Impact of #Penicillin #Allergy Labels on #Antimicrobial Stewardship in #Sepsis and Associated #Pharmacoeconomics - an observational cohort study ( #IMPALAS Study) https://t.co/Jj1PVBeZ8U pic.twitter.com/EjcTrJVhAd
— JACI: In Practice (@JACIInPractice) January 8, 2020
Two papers on Xpert MTB/RIF Ultra. 1: Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous #meningitis: a prospective, randomised, diagnostic accuracy study https://t.co/DS4PFLaFUH #TB #tuberculosis
— The Lancet Infectious Diseases (@TheLancetInfDis) January 8, 2020
NEW🔥 propensity score analysis in CID @MonicaL_Nation @peripatetical
— Antibiotic Steward 🆔 (@ABsteward) January 6, 2020
Influenza vaccine effectiveness against influenza-related mortality in 🇦🇺 hospitalized patients
Vaccination was associated with a 31% ⬇️ in influenza-related mortality. #IDTwitter https://t.co/SDWAnc6qLw pic.twitter.com/R0266Eggwh
🚨Important study in #TxID!🚨
— Ilan Schwartz MD PhD 🔬🍄🤒 (@GermHunterMD) January 9, 2020
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Studyhttps://t.co/mhwz9iLB4o pic.twitter.com/Uq9WCBdkn8
NEW 🔥🔥 in #JACnews
— Antibiotic Steward 🆔 (@ABsteward) January 6, 2020
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study. #IDTwitter @erin_barreto https://t.co/Kyb2JDCfa3 pic.twitter.com/2fN975jbZW
Sensational -- even inspirational! -- work done by my colleagues @ChristinPrice @dsolsMD and others at @BrighamWomens, giving people who inject drugs the option of home IV antibiotic therapy. @commonhealth 👏👏👏https://t.co/0cf0ZRUKdw
— Paul Sax (@PaulSaxMD) January 9, 2020
Prevalence of HPV Infection by Number of Vaccine Doses Among US Women | Bad news, only 51% of adolescent women in the US have completed HPV vaccination series; good news, protection after only 1 dose similar to 2 or 3 doses. @JAMANetworkOpen https://t.co/hlHC8fowpd
— Carlos del Rio (@CarlosdelRio7) January 4, 2020
This is the most foundational paper in IAIs I know. Everyone should read it. https://t.co/kXl4115kiw
— Jason Gallagher (@JGPharmD) January 5, 2020
💊❌"Antimicrobial resistance and antimicrobial stewardship in #neonatal and #paediatric care" is one of the four main topics that we will focus on during the @MSF Paediatric Days 2020 in Dakar.#PaedsDakar2020 #AntibioticResistance
— MSFPaediatrics (@MSFPaedsDays) January 7, 2020
👉https://t.co/l7BV6jZzF8 https://t.co/V0HRo30hfn
A NEW🔥 case report in OFID @elopriore and Prof. David Livermore
— Antibiotic Steward 🆔 (@ABsteward) January 9, 2020
Successful Treatment with Tigecycline monotherapy of Acute Prostatitis Caused by Multidrug-resistant Escherichia coli Harboring NDM 1 /CMY2 acquired AmpC / TEM 164H ESBL. #IDTwitter https://t.co/enSMJDLKEf pic.twitter.com/aLT6KjAq1H
Added clinical data to support n#3
— Antibiotic Steward 🆔 (@ABsteward) January 5, 2020
Study @pranita_tamma
Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections with a Positive Culture for Enterococcus faecalis. No difference between TZP or Ertapenem. #IDTwitter https://t.co/OIQjVBGoVC
NEW 🔥in AAC @ASMicrobiology Meropenem-vaborbactam exhibited almost complete activity against Enterobacterales (>99.9% susceptible), including CRE, and was also very active against P. aeruginosa isolates (89.5% susceptible). #IDTwitter https://t.co/0vwLFeHwIx
— Antibiotic Steward 🆔 (@ABsteward) January 7, 2020
And add enteroccocus to the list of bloodstream infections that can be improved with ID consult and/or following appropriate process measureshttps://t.co/KbjBaKiD3G
— Eric Wenzler (@TheIDApprentice) January 6, 2020
NEW 🔥in AAC @jasonroberts_pk @AntonPeleg Prof. J. Mouton "RIP"
— Antibiotic Steward 🆔 (@ABsteward) January 7, 2020
Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales. #IDTwitter https://t.co/mAuplh3Xku pic.twitter.com/8VVrxwU4vL
Huge congrats to @idpharmd, one of 25 global experts (and the only US pharmacist) selected by @WHO to help healthcare professionals and government leaders in LMICs implement antimicrobial stewardship plans! @osu_pharmacy @OSUWexMed https://t.co/6iL8lUS7he
— CIDRAP-ASP (@CIDRAP_ASP) January 7, 2020
Nurse prompting for prescriber-led review of antimicrobial use associated with a 20% decrease in antibiotic use in critical care 👏👏 @abx_canuck https://t.co/ZZf7ZEYRlx via @ajccme
— Brad Langford (@BRxAD) January 7, 2020
Hong Kong activates ‘serious response level’ for infectious diseases as Wuhan pneumonia outbreak escalates.
— Sari Arho Havrén (@SariArhoHavren) January 4, 2020
I hope Hong Kong has learned from SARS as cases in Wuhan climb to 44. (official number.. how many outside of Wuhan by now?) https://t.co/gLbqtp4WZT
💉Discover the role vaccines play in preventing infectious diseases as well as exploring their potential for addressing antimicrobial resistance with our FREE 2 week course. Join here! https://t.co/5yY58xi5Al #AMR #StopSuperbugs
— BSAC (@BSACandJAC) January 6, 2020
Meet the virus hunters. These scientists are doing amazing work all over the world to stop infectious diseases. https://t.co/zsCpJGs9c8
— Rotary International (@Rotary) January 5, 2020
#OSURx assoc. prof. Debra Goff (@idpharmd) is 1 of 25 global experts (only American #pharmacist) selected by @WHO to help low- and middle-income counties with antimicrobial stewardship to reduce the risk of #antibioticresistance. https://t.co/Fd8FbGgdEA @OSUWexMed pic.twitter.com/wiyoW8HpgE
— Ohio State Pharmacy (@osu_pharmacy) January 9, 2020
Unfortunately weve been seeing more and more of these DAP +/- LZD resistant VREs esp. in our transplant patients. We hope our approach to this one is interesting and maybe even semi helpful! @PrecisionAbxLab@MRSAsantarossa@loyola_asp @aharrington1884https://t.co/CAq1A3Gqis
— Eric Wenzler (@TheIDApprentice) January 4, 2020
Virologists weigh in on novel #coronavirus in China's outbreak https://t.co/mWR1Caahzb pic.twitter.com/qwXz3fpzOv
— CIDRAP (@CIDRAP) January 8, 2020
D#7. Major cause of mortality after influenza A is bacterial pneumonia. In particular, as @findingpneumo thought me., Strep. pneumoniae. Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications. https://t.co/Dr83p9VDqd
— Carlos del Rio (@CarlosdelRio7) January 5, 2020
Contagion is talking to experts in antimicrobial stewardship to explore the myths and realities of #antibiotic use. Dr. Conan MacDougall @ConanMacDougall shares this week’s Monday #StewardTip:https://t.co/96bxCmzwRL pic.twitter.com/NS23jy8urk
— Contagion (@Contagion_Live) January 6, 2020
NEW🔥 in OFID @Siyun_Liao @madhuri_id
— Antibiotic Steward 🆔 (@ABsteward) January 8, 2020
Out of Sight – Out of Mind: Impact of Cascade Reporting on Antimicrobial Usage. #IDTwitter https://t.co/eVEXMTulX8 pic.twitter.com/R1Zc144jRD
Mystery #Pneumonia Has Afflicted 44 People In #Wuhan, China.
— Microbes&Infection (@MicrobesInfect) January 4, 2020
Health officials have ruled out common causes of viral pneumonia such as influenza, avian influenza, adenovirus infection.
Authorities are looking into possible exposures to sea creatures.https://t.co/uGty5XkAOf
Can one use "Once-daily #tigecycline for #outpatient #parenteral #antibiotic #therapy: a single-centre observational study"..? TO find out more, READ the latest original #article in #JACAMR now for FREE: https://t.co/DPQ2qtKvEU @eopat @BSACandJAC #JACAMRnews #OPAT #antimicrobial pic.twitter.com/8JIM9Fyp5P
— Gavin Barlow (@gavin_barlow) January 6, 2020
A new coronavirus identified by Chinese scientists is the putative cause of an outbreak of unusual #WuhanPneumonia in the central city of #Wuhan.
— Microbes&Infection (@MicrobesInfect) January 10, 2020
The novel #coronavirus resembles known bat viruses, but not the coronaviruses that cause #SARS & #MERS.
https://t.co/t5WDcorXlR
Calling all #OPAT practitioners: Did you know that once-daily tigecycline can be successfully used for management of complex infections? Find out more in the latest edition of #JACAMR https://t.co/ypOTXn7YQJ
— BSAC (@BSACandJAC) January 8, 2020
Combining Multiple Antibiotics May Make Bacteria More Likely to Develop Resistance.
— Microbes&Infection (@MicrobesInfect) January 10, 2020
Once pathogens become tolerant of one drug, they are more likely to become resilient against others, a clinical study finds.https://t.co/T3VPErvIna #AntibioticResistance pic.twitter.com/uAv8Cokzft
Discontinuing Contact Precautions for VRE is associated with rising VRE bloodstream infection rates in Ontario hospitals, 2009 – 2018, a quasi-experimental study @PublicHealthON @IDSAInfo https://t.co/JwYWUlnQRk
— Kevin Schwartz (@DrKevinSchwartz) January 10, 2020
The world’s deadliest animal spreads malaria, dengue, West Nile virus, yellow fever, Zika, and other infectious diseases. Learn more about CDC’s leading efforts to prevent and respond to mosquito-borne disease threats. https://t.co/oPr0bhCKAu pic.twitter.com/kU67wbURuJ
— CDC Global Health (@CDCGlobal) January 6, 2020
Early-life antibiotics have long-term consequences on the murine gut microbiota and enteropathogen infection susceptibility @mbiojournal https://t.co/7eA3aSmgI6 pic.twitter.com/duklaJosK5
— ASM (@ASMicrobiology) January 7, 2020
China's #WuhanPneumonia #coronavirus
— Microbes&Infection (@MicrobesInfect) January 10, 2020
“A cluster of patients with an unusual respiratory infection is a worry. The level of concern raises again when the illness is linked to an animal food source. This is how new viruses jump across the species barrier.”https://t.co/VlIdE9DZuv
New online: Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999–2019: an epidemiological investigation https://t.co/c5AmIQQ8p4
— The Lancet Infectious Diseases (@TheLancetInfDis) January 8, 2020
Speaking about blood cultures during @Emory_MedMicro rounds. This is a good review: Blood culture-based diagnosis of bacteraemia: state of the art #IDTwitter #MedEd https://t.co/Gqz9zjg0Yk
— Carlos del Rio (@CarlosdelRio7) January 6, 2020
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis | Infectious Diseases | JAMA Network Open | JAMA Network https://t.co/ESGjkihSZQ
— Prof Didier Pittet (@DidierPittet) January 9, 2020
.@60minutes shares how antibiotic overuse in livestock is fueling the spread of antibiotic-resistant bacteria. #DISARMSuperbugs https://t.co/yfz4YnhKHU
— IDSA (@IDSAInfo) January 6, 2020
📢News Alert
— BSAC (@BSACandJAC) January 6, 2020
We have updated our MRSA treatment guidelines. You can find the new guidance here: https://t.co/9DDgKtikPq
Please RT and share with colleagues. Together we can #StopSuperbugs
A new #coronavirus may be the pathogen causing China’s mysterious #pneumonia cases, @WHO announced on Wednesday. @HelenBranswell reports. https://t.co/WAgeAlLVau
— IDSA (@IDSAInfo) January 9, 2020
TpiA (triosephosphate isomerase) plays an essential role in the metabolism of P. aeruginosa and influences bacterial virulence and antibiotic resistance @mbiojournal https://t.co/UmyGLon8dV pic.twitter.com/0j1vlAXqHv
— ASM (@ASMicrobiology) January 8, 2020
Add this article to the mounting evidence that ID consult👩⚕️and collaborative bundles decrease mortality in bacteremia, most recent benefit found in patients with Enterococcal bloodstream infections
— SIDP (@SIDPharm) January 8, 2020
Available at https://t.co/pMcl4IxKwo pic.twitter.com/SHLegdzf55
But have you read this during the holidays? Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections. - PubMed - NCBI https://t.co/krFj19EWJj
— ACCP INFD PRN (@accpinfdprn) January 8, 2020
D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotics have similar outcomes to longer courses. Read the STOP-IT trial published in @NEJM https://t.co/9fL18K4WkU
— Carlos del Rio (@CarlosdelRio7) January 7, 2020
Can Hantavirus infection cause predominantly renal failure and proteinuria in North America?
— Andrés Henao (@andhen25) January 8, 2020
Yes, it can! Check our latest report
Emerging Infectious Diseases journal - CDC https://t.co/k76120vy4b via @CDCgov
A mysterious viral #pneumonia that has infected dozens in central China is not #SARS, health chiefs said.
— Microbes&Infection (@MicrobesInfect) January 5, 2020
They also discounted #birdflu & #MERS.
A total of 59 cases have been reported in the city of #Wuhan, 7 of which are considered critical.https://t.co/U7UJCc8SUa pic.twitter.com/gT3YPFSoNo
Wall Street Journal: 'Many makers of newly-approved antibiotics to treat superbugs are struggling to generate sales & are running out of cash' #StopSuperbugs https://t.co/oSJWb5zXpg via @WSJ
— Antibiotic Action (@TheUrgentNeed) January 6, 2020
Created by Cameron Forbes. Last updated January 18, 2020 at 05:08 EST.